These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27593248)

  • 1. Clinical PET/MR Imaging in Dementia and Neuro-Oncology.
    Henriksen OM; Marner L; Law I
    PET Clin; 2016 Oct; 11(4):441-52. PubMed ID: 27593248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/MRI: Multiparametric imaging of brain tumors.
    Ferda J; Ferdová E; Hes O; Mraček J; Kreuzberg B; Baxa J
    Eur J Radiol; 2017 Sep; 94():A14-A25. PubMed ID: 28283219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.
    Neuner I; Kaffanke JB; Langen KJ; Kops ER; Tellmann L; Stoffels G; Weirich C; Filss C; Scheins J; Herzog H; Shah NJ
    Eur Radiol; 2012 Dec; 22(12):2568-80. PubMed ID: 22777617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workflow in Simultaneous PET/MRI.
    Barbosa Fde G; von Schulthess G; Veit-Haibach P
    Semin Nucl Med; 2015 Jul; 45(4):332-44. PubMed ID: 26050660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain PET and functional MRI: why simultaneously using hybrid PET/MR systems?
    Cecchin D; Palombit A; Castellaro M; Silvestri E; Bui F; Barthel H; Sabri O; Corbetta M; Bertoldo A
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):345-359. PubMed ID: 28750494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.
    Verburg N; Pouwels PJ; Boellaard R; Barkhof F; Hoekstra OS; Reijneveld JC; Vandertop WP; Wesseling P; de Witt Hamer PC
    Neurosurgery; 2016 Oct; 79(4):535-40. PubMed ID: 27479710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/MR in dementia and other neurodegenerative diseases.
    Barthel H; Schroeter ML; Hoffmann KT; Sabri O
    Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.
    Hitz S; Habekost C; Fürst S; Delso G; Förster S; Ziegler S; Nekolla SG; Souvatzoglou M; Beer AJ; Grimmer T; Eiber M; Schwaiger M; Drzezga A
    J Nucl Med; 2014 Jun; 55(6):923-31. PubMed ID: 24833495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
    Fowler KJ; McConathy J; Narra VR
    J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid imaging with PET/MRI: ready for clinical routine?
    Ferda J
    Eur J Radiol; 2017 Sep; 94():A1-A2. PubMed ID: 28551301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET with radiolabeled aminoacid.
    Crippa F; Alessi A; Serafini GL
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid MR-PET in Neuroimaging.
    Bisdas S; Lá Fougere C; Ernemann U
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():275-81. PubMed ID: 26227618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of PET/MRI in oncology.
    Sotoudeh H; Sharma A; Fowler KJ; McConathy J; Dehdashti F
    J Magn Reson Imaging; 2016 Aug; 44(2):265-76. PubMed ID: 27007987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment.
    Zhu T; Das S; Wong TZ
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):377-430. PubMed ID: 28390536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.